| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 05/01/2007 | CA2086832C Hepatitis a virus strain, method for the isolation of new hepatitis a virus strains and hepatitis a vaccines |
| 04/26/2007 | WO2007047938A2 Influenza viruses able to infect canids, uses thereof |
| 04/26/2007 | WO2007047581A2 Pulmonary stem cells, related methods and kits |
| 04/26/2007 | WO2007047256A2 Svv-based animal vaccines and uses thereof |
| 04/26/2007 | WO2007046962A2 Cell lines harboring hepatitis virus and methods for using thereof |
| 04/26/2007 | WO2007045045A1 Antiviral resistance mutants and applications thereof |
| 04/26/2007 | WO2007008918A3 Virus vaccines comprising envelope-bound immunomodulatory proteins and methods of use thereof |
| 04/26/2007 | WO2006133795A3 A new human t-cell lymphotropic virus (htlv-3): nucleic acid and peptidic sequences thereof and method for detecting htlv-3 |
| 04/26/2007 | WO2006104615A3 Influenza nucleic acids, polypeptides, and uses thereof |
| 04/26/2007 | WO2006073441A3 High throughput assays for transmissible spongiform encephalopathies (tse) |
| 04/26/2007 | US20070093441 useful to efficiently induce self-specific immune responses; comprising a virus-like particle and at least one protein, or peptide of IL-5, IL-13 and/or eotaxin |
| 04/26/2007 | US20070092960 Method for high throughput volumes in the fractionation of bio-molecules by chromatographic systems |
| 04/26/2007 | US20070092866 Avian adenoassociated virus and uses thereof |
| 04/26/2007 | US20070092536 Cold-adapted equine influenza viruses |
| 04/26/2007 | US20070092534 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses |
| 04/26/2007 | CA2626672A1 Antiviral resistance mutants and applications thereof |
| 04/26/2007 | CA2626489A1 Influenza viruses able to infect canids, uses thereof |
| 04/26/2007 | CA2626452A1 Canine influenza virus and related compositions and methods of use |
| 04/26/2007 | CA2625619A1 Cell display of antibody libraries |
| 04/26/2007 | CA2597921A1 New live virus vaccines |
| 04/25/2007 | EP1776957A2 Use of herpes vectors for tumor therapy |
| 04/25/2007 | EP1506287B1 Methods of adenovirus purification |
| 04/25/2007 | EP1190056B1 Human cytokine receptor |
| 04/25/2007 | CN1954066A Cellular and viral inactivation |
| 04/25/2007 | CN1951398A Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies |
| 04/25/2007 | CN1312171C DNA vaccines encoding HIV accessory proteins |
| 04/24/2007 | US7208655 A plant virus containing a predetermined foreign peptide as part of the coat protein of the virus |
| 04/24/2007 | US7208315 Compositions and methods for efficient AAV vector production |
| 04/24/2007 | US7208299 Controlling adhesion of cells to hydrophobic surfaces using biomolecule conjugated end group activated polymer |
| 04/24/2007 | US7208293 Directed evolution of novel binding proteins |
| 04/24/2007 | US7208165 Human cytomegalovirus DNA sequences |
| 04/24/2007 | US7208164 Administering a vaccine contains an immunogenically effective amount of a live, avirulent strain of infectious bronchitis virus, in ovo of a fertile egg of a chicken |
| 04/24/2007 | US7208163 Method for producing temperature-sensitive morbillivirus |
| 04/24/2007 | US7208161 Chimeric viral particle for use as tool in the prevention and treatment of bacterial and viral disease in humans |
| 04/24/2007 | CA2220997C Adenovirus vectors for gene therapy |
| 04/24/2007 | CA2141951C Inhibition of retrovirus infection |
| 04/19/2007 | WO2007010398A3 Caveolin-3 and in vitro culture of hepatitis c virus |
| 04/19/2007 | WO2006136566A9 Process for the preparative purification of virus-like particles (vlps) |
| 04/19/2007 | WO2006132681A3 Methods for identifying compounds that inhibit hiv infection |
| 04/19/2007 | WO2006093661A3 A method of truncating both ends of a large piece of dna |
| 04/19/2007 | WO2005035712A3 Methods and compositions for infectious cdna of sars coronavirus |
| 04/19/2007 | US20070089197 Papaya ringspot virus genes |
| 04/19/2007 | US20070087434 Antiviral artificial cell |
| 04/19/2007 | US20070087433 Adeno-associated viral vector for use as heterologous gene transfer agent |
| 04/19/2007 | US20070087332 Pulmonary stem cells, related methods and kits of parts |
| 04/19/2007 | US20070087330 Viral deconstruction through capsid assembly in vitro |
| 04/19/2007 | US20070087015 Multivalent dengue virus vaccine |
| 04/19/2007 | US20070086984 Viruses for the Treatment of Cellular Proliferative Disorders |
| 04/18/2007 | EP1775000A2 Method of producing universal blood plasma from blood |
| 04/18/2007 | EP1774049A1 Compositions and methods for determining resistance to inhibitors of virus entry using recombinant virus assays |
| 04/18/2007 | EP1773387A2 Avipox recombinants expressing foot and mouth disease virus genes |
| 04/18/2007 | EP1441761B1 Methods of preventing and treating flavivirus infection in animals |
| 04/18/2007 | EP0739414B1 Herpesvirus replication defective mutants |
| 04/18/2007 | CN1950507A Recombinant varicella-zoster virus |
| 04/18/2007 | CN1950499A 黄病毒疫苗 Flavivirus vaccines |
| 04/18/2007 | CN1948468A Hybridization immune deficiency virus strain and application |
| 04/18/2007 | CN1311084C Highly-sensitive genomic assays employing chimeric bacteriophage standards |
| 04/17/2007 | US7205280 Methods of suppressing microglial activation |
| 04/17/2007 | US7205126 Made by disrupting HPV-virus-like particles including a chelating agent, mixing them with plasmids and reassembling them into the pseudoviruses (VLPs with plasmids inside) adding a stop buffer to reassemble the VLPs into pseudoviruses; administering to the mucosa; can be applied in gene therapy |
| 04/17/2007 | US7205125 Mixed Virus-like particles |
| 04/17/2007 | US7205013 Infectious Respiratory Syncytial Viral particle for use as gene transfer tool in genetic engineering |
| 04/17/2007 | CA2166118C Adenovirus vectors for gene therapy |
| 04/17/2007 | CA2149420C Microporous macrocapsules |
| 04/17/2007 | CA2141212C Defective adenovirus and corresponding complementation lines |
| 04/12/2007 | WO2007040242A1 Isolated human cell, method for obtaining the same and their use |
| 04/12/2007 | WO2007039552A1 Interleukin-1 conjugates and uses thereof |
| 04/12/2007 | WO2007039069A1 Method for the detection of the removal of viruses to validate filters and filtering processes |
| 04/12/2007 | WO2005107796A3 Cellular permissivity factor for viruses, and uses thereof |
| 04/12/2007 | US20070082392 modified erythrocytes of the present invention comprise CD4 and at least one HIV coreceptor, such as CXCR4 or CCR5. The modified erythrocytes, when administered to an HIV patient, bind to the plasma virus and induce the injection of the HIV ribonucleoprotein complex into the cells |
| 04/12/2007 | US20070082388 increasing fficiency of transduction of hematopoietic cells; infecting cells in presence of fibronectin; stem cells; gene therapy; efficient retroviral infection of mammalian cells |
| 04/12/2007 | CA2623287A1 Interleukin-1 conjugates and uses thereof |
| 04/11/2007 | EP1771552A2 Influenza hemagglutinin and neuraminidase variants |
| 04/11/2007 | CN1944638A Inactivating method for virus in blood products |
| 04/11/2007 | CN1309836C Methods to culture circovirus |
| 04/10/2007 | US7202214 Rhizoc3 antimicrobial polypeptides and their uses |
| 04/10/2007 | US7202078 Composition intended for the preservation of infectious recombinant adenoviruses |
| 04/10/2007 | US7201909 Genetic engineering; genome dsegment containing identifying phenotype; generation immunology response |
| 04/10/2007 | US7201895 High-affinity antagonists of ELR-CXC chemokines |
| 04/10/2007 | CA2199131C Retroviral vector hybrids and the use thereof for gene transfer |
| 04/10/2007 | CA2154023C Recombinant infectious non-segmented negative strand rna virus |
| 04/10/2007 | CA2071016C Method for detecting bovine diarrhoea virus infection nucleotide sequence encoding a protein induced by this virus infection and recombinant proteins and antigens relating thereto |
| 04/05/2007 | WO2007038145A2 Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications |
| 04/05/2007 | WO2007037429A1 Novel recombinant human hepatitis c virus-like particle and method for producing the same |
| 04/05/2007 | WO2007037428A1 High production system for infectious hepatitis c virus particle |
| 04/05/2007 | WO2007037273A1 Introduction of substance into cell by using nanoparticle having cell membrane-permeable peptide displayed thereon |
| 04/05/2007 | WO2007011210A3 Parechovirus, vaccines, medicaments and diagnostic kits |
| 04/05/2007 | WO2007006031A3 Method for the preparation of prrs virus and proteins of and diagnostic test kits for detecting them |
| 04/05/2007 | WO2006110689A3 Method of increasing the function of an aav vector |
| 04/05/2007 | US20070077650 Production of replication deficient retroviral vector particles from retroviruses which capable of transducing cells; gene therapy |
| 04/05/2007 | US20070077584 Fat metabolism; bioassay |
| 04/05/2007 | US20070077226 Gutless adenovirus vector and the construction method thereof |
| 04/05/2007 | CA2624242A1 High production system for infectious hepatitis c virus particle |
| 04/05/2007 | CA2624130A1 Novel recombinant human hepatitis c virus-like particle and method for producing the same |
| 04/05/2007 | CA2621466A1 Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications |
| 04/04/2007 | EP1768697A2 Recombinant rabies virus compositions |
| 04/04/2007 | EP1105497B1 Cold-adapted equine influenza viruses |
| 04/04/2007 | EP1054988B1 Anti-viral vectors |
| 04/04/2007 | CN1942585A Nucleic acid construct containing full-length genome of human hepatitis c virus, recombinant full-lenght virus genome replicative cell having the nucleic acid construct transferred thereinto and metho |
| 04/04/2007 | CN1942578A Low virulent strain of recombinant newcastle disease lasota vaccine expressing HA protein of avian influenza-H5 virus |
| 04/04/2007 | CN1942577A Method and kits for predicting infectious disease state |